The regenerative capacity of the adult mammalian heart is limited, because of the reduced ability of cardiomyocytes to progress through mitosis 1 . Endogenous cardiomyocytes have regenerative capacity at birth but this capacity is lost postnatally, with subsequent organ growth occurring through cardiomyocyte hypertrophy 2,3 . The Hippo pathway, a conserved kinase cascade, inhibits cardiomyocyte proliferation in the developing heart to control heart size and prevents regeneration in the adult heart 4,5 . The dystrophinglycoprotein complex (DGC), a multicomponent transmembrane complex linking the actin cytoskeleton to extracellular matrix, is essential for cardiomyocyte homeostasis. DGC deficiency in humans results in muscular dystrophy, including the lethal Duchenne muscular dystrophy. Here we show that the DGC component dystroglycan 1 (Dag1) directly binds to the Hippo pathway effector Yap to inhibit cardiomyocyte proliferation in mice. The Yap-Dag1 interaction was enhanced by Hippo-induced Yap phosphorylation, revealing a connection between Hippo pathway function and the DGC. After injury, Hippo-deficient postnatal mouse hearts maintained organ size control by repairing the defect with correct dimensions, whereas postnatal hearts deficient in both Hippo and the DGC showed cardiomyocyte overproliferation at the injury site. In the hearts of mature Mdx mice (which have a point mutation in Dmd)-a model of Duchenne muscular dystrophy-Hippo deficiency protected against overload-induced heart failure.
letter reSeArCH cardiomyocytes had a broad range of orientations and appeared disorganized (Extended Data Fig. 1n, o) , indicating that cardiomyocyte outgrowth in the Salv;Mdx dKO secondary apex was uncoordinated. This overgrowth phenotype suggests that the Hippo pathway and DGC cooperatively limit tissue growth after injury and that DGC function is required for the normal three-dimensional organization of regenerating cardiomyocytes.
We have previously shown cellular protrusions in the regenerating Salv cKO border zone cardiomyocytes 6 . In regenerative stage hearts, when Hippo activity is low, protrusion formation promoted regeneration, however, Mdx cardiomyocytes failed to make protrusions and regenerate, indicating the requirement of dystrophin 6 . We determined whether protrusion formation could be rescued after injury at the non-regenerative stage in Salv;Mdx dKO adult hearts. Whereas Salv cKO border zone cardiomyocytes formed protrusions, Salv;Mdx dKO cardiomyocytes failed to make protrusions (Extended Data Fig. 2a-e ). Similarly, vinculin expression was increased in Salv cKO border zone cardiomyocytes but not in those of other groups (Extended Data Fig. 2f-m) . In vitro migration studies also revealed that dystrophin deficiency in Salv;Mdx dKO hearts suppressed the migratory phenotype of Salv cKO cardiomyocytes (Extended Data Fig. 2n-r ), suggesting that the disorganized morphology of regenerated cardiomyocytes in Salv;Mdx dKO hearts was due to the lack of protrusion formation.
DNA synthesis and expression of the mitosis and cytokinesis marker aurora kinase B (Aurkb) were increased in injured Salv;Mdx dKO cardiomyocytes compared to injured control cardiomyocytes ( Fig. 1k, l) , indicating enhanced myocardial proliferation in Salv;Mdx dKO hearts. After apical resection, Salv cKO and Salv;Mdx dKO cardiomyocytes showed increased cytokinesis compared to control cardiomyocytes ( Fig. 1l-p ). Similar to DNA synthesis, cytokinesis was increased in Salv;Mdx dKO cardiomyocytes compared to Salv cKO cardiomyocytes. These results indicate that the Hippo pathway and DGC cooperatively inhibit cardiomyocyte cell cycle progression.
To investigate whether the DGC regulates Yap by altering its subcellular localization after injury, we examined Yap localization in border zone cardiomyocytes after apical resection. The number of cardiomyocytes with nuclear Yap was low in control and Mdx hearts ( Fig. 2a, b , e, f, i), but was increased in Salv cKO hearts ( Fig. 2c , g, i), as reported previously 6 . In Salv;Mdx dKO hearts, Yap was localized in the nucleus of most cardiomyocytes ( Fig. 2d , h, i). Furthermore, the expression of Yap targets Ccne2 and talin was upregulated in Salv cKO and Salv;Mdx dKO cardiomyocytes ( Fig. 2j- Fig. 3p and Extended Data Fig. 6e -l). The higher number of cardiomyocytes in Salv;Mdx dKO hearts than in Mdx hearts was partly because of reduced apoptosis, particularly one week after TAC ( Fig. 3q and Extended Data Fig. 6m-t ). Furthermore, cytoplasmic levels of phosphorylated (p)Yap were lower in Salv cKO and Salv;Mdx dKO cardiomyocytes than in control and Mdx cardiomyocytes (Extended Data Fig. 7a -i). Unlike in the resection model, vinculin expression was comparable among the four genotypes (Extended Data Fig. 7j -q). These results suggest that suppression of Mdx cardiomyopathy by deleting Salv is due to increased cardiomyocyte proliferation and, immediately after TAC, to reduced apoptosis.
To investigate Hippo deficiency in Mdx C57BL/10J mice using gene therapy, we performed TAC and injected an adeno-associated virus 9 (AAV9) encoding Salv short hairpin RNA (shRNA) or a control virus ( Fig. 8f -k). The mRNA levels of Yap target genes encoding proteins that regulate cell proliferation increased to a greater extent than those genes encoding cytoskeletal components ( Fig. 3u ), perhaps reflecting differences in sensitivity to Yap.
We determined whether DGC complex components directly interact with Yap in control and Mdx P12 heart extracts. Dag1 contains a 'PPxY' motif that binds WW-domain-containing proteins, such as Yap and dystrophin 12 . Yap pull-down assays showed that Yap associated with DGC components Sgcδ and Dag1 in control, but not in Mdx, extracts, whereas the interaction between Yap and Lats2, as well as an interaction between Yap and α -catenin was detected in both control and Mdx extracts ( Fig. 4a ). Dag1 pull-down assays revealed that Dag1 associated with Sgcδ and Yap in control, but not in Mdx, extracts (Fig. 4b ). Lats2 did not associate with Dag1, suggesting that Hippo pathway components did not form a complex with the DGC. Using the C2C12 myoblast cell line, we found that Yap interacted with DGC components, but that the interaction was disrupted when the gene encoding dystrophin (Dmd) was knocked down (Extended Data Fig. 9a, b ).
pYap was present in the DGC ( Fig. 4b and Extended Data Fig. 9d ), suggesting that Yap phosphorylation by Lats kinase promotes the interaction between Yap and the DGC. To test this, we examined the interaction between Yap and the DGC in cardiac extracts from letter reSeArCH transgenic mice expressing Flag-tagged Yap-Yap(5SA)-that is not affected by the Hippo kinase cascade in adult cardiomyocytes 13 . Yap(5SA) did not interact with DGC components or Lats2 but did interact with α -catenin ( Fig. 4c, d ). In Yap(5SA)-transfected C2C12 cells, neither DGC components nor Lats2 interacted with Yap(5SA) (Extended Data Fig. 9c, d ). Dag1 interacted with endogenous Yap but not Yap(5SA) ( Fig. 4d and Extended Data Fig. 9d ). Similar to what we observed in the heart, Lats2 and Dag1 did not interact in C2C12 cells (Extended Data Fig. 9d ).
C2C12 cell fractionation experiments revealed that, in control cells, Yap was localized in the plasma membrane, cytoplasm and nuclear fractions ( Fig. 4e-h ). Compared to control cells, C2C12 cells with Salv or Salv;Dmd knockdown showed decreased Yap localization in the plasma membrane and cytoplasmic fractions and increased Yap localization in the nuclear fraction ( Fig. 4e-h) . In contrast to cardiomyocytes, C2C12 cells with Dmd knockdown had more nuclear Yap. A difference between C2C12 cells and cardiomyocytes is the presence of the intercalated disc (ICD) in mature cardiomyocytes. Because Yap binds α -catenin, which localizes to the ICD in cardiomyocytes, Yap binding to the ICD may compensate for DGC deficiency in cardiomyocytes 14 (Fig. 4a, c) . Super-resolution microscopy revealed that Yap colocalized with Dag1 in the plasma membrane in control, but not in Mdx, cardiomyocytes ( Fig. 4i-l) . However, Yap colocalized in the ICD with connexin 43 (Cx43) in both control and Mdx cardiomyocytes ( Fig. 4m-p) . In addition, experiments with purified GST-fusion proteins revealed that Yap directly bound Dag1 through the Dag1 PPxY motif but did not directly interact with Sgcδ ( Fig. 4q ). Therefore, Yap phosphorylation is not required for Dag1 binding in vitro. Collectively, these data suggest that Hippo phosphorylation of Yap promotes the Yap-DGC complex formation in vivo.
The DGC is a node for mechanical signalling. Mechanical signalling regulates Yap subcellular localization, but the mechanism is poorly understood 15 . Our data reveal that the DGC sequesters pYap, perhaps to prevent the action of activating phosphatases, as a mechanism to regulate cardiomyocyte proliferation in the postnatal and adult heart (Extended Data Fig. 10 ). Our findings suggest exquisite coordination of extracellular and mechanical signalling with nuclear events in the context of a mechanically stressed cardiomyocyte. The Hippo-Yap-DGC negative regulatory loop is dysfunctional in the stressed cardiomyocyte, preventing an adequate proliferative response. Our findings also indicate that Hippo signalling is maladaptive in cardiomyopathy associated with Duchenne muscular dystrophy and raise the possibility that Hippo deficiency, in combination with other approaches such as gene editing, can be used to treat muscular dystrophy [16] [17] [18] .
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. For each experimental group, we studied a minimum of 3 mice that were randomized using block randomization. We estimated sample sizes based on our pilot studies. Mice were used for these studies because they are amenable to genetic manipulation and can be made into models of human diseases. All animal protocols and procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Baylor College of Medicine in Houston, Texas. For all surgeries and echocardiographic studies, researchers were blinded to mouse genotypes. Apical resection. Resection of the heart apex or sham surgery was performed at P8 in mice, as previously described 4 . Tamoxifen (50 mg) was injected daily from P7 to P10. Hearts were collected at 4 and 21 days after resection. For data in Fig. 1 , sham or apical resection was performed in non-regenerative-stage hearts (P8) of control, Mdx, Salv cKO, and Salv;Mdx dKO mice. All mice carried the Myh6-Cre ERT ;mTmG allele, and tamoxifen was administered daily from P7 to P10. Transverse aortic constriction (TAC). Mice were challenged with TAC because Mdx mice have a mild phenotype and develop cardiomyopathy after ageing to approximately 15 months 19 . On the day of surgery and one day after surgery, 9-to 10-week-old mice were injected with tamoxifen (150 mg). The thoracic aorta between the carotid arteries was constricted using 6-0 silk thread between the carotid arteries. Mice that did not survive overnight from the surgery were excluded. Echocardiographic analysis was performed on the day before surgery and two weeks after the surgery. For the studies involving AAV9 infection, echocardiography was performed before surgery and 2, 8 and 11 weeks after surgery. TAC and sham surgeries were performed in C57BL/10J Mdx mice. For knockdown studies, AAV-GFP (green-fluorescent protein) or AAV-Salv virus was administered at the time of surgery. In Fig. 3r , s, Mdx sham groups before viral injection at week 0 were collapsed into one group (sham pre-treatment). Cardiac function analysis. Echocardiography was performed in the Baylor College of Medicine Mouse Phenotyping Core. Transthoracic echocardiography was performed using the VisualSonics Vevo 2100 system equipped with a 40-Mhz 550-s probe. Mice were anaesthetized with 2% isoflurane inhalation (driven by 2 l min −1 oxygen) and placed on a heated platform (37 °C) with integrated physiologic monitoring capabilities. Two-dimensional B-mode imaging was used to capture the long-axis projection with guided M-mode images, and a PW Doppler pulse wave was recorded for associated echocardiographic measurements. The average reading for each echocardiographic parameter was recorded from at least three distinct frames from each mouse. AAV9 targeting Salv. The parental vector pENN-AAV-cTnT, p1967-Q was obtained from the University of Pennsylvania Vector Core. A triple miR30-flanked shRNA directed against Salv was cloned downstream of a GFP reporter. The subsequent construct was packed into AAV9 by the IDDRC Neuroconnectivity Core at Baylor College of Medicine. Mice were administered a single retro-orbital injection of virus with a total of 1 × 10 12 viral genomes delivered, and TAC or sham surgery was performed. Hearts were collected 13 weeks after the surgery. Histologic analysis. For apical resection studies, hearts were collected three weeks after the surgery. For TAC genetic studies, hearts were collected two weeks after surgery. Hearts were fixed in 10% formalin, embedded into paraffin and sectioned for further analysis. For AAV9 studies, hearts were collected 11 weeks after surgery; hearts were then frozen and sectioned for further analysis.
Trichrome staining was performed to determine the degree of heart injury or fibrosis. Fibrotic scarring stained blue, and scar size was measured using ImageJ software. The size of the extra apex was determined by drawing a line at the site of resection and measuring the area outside of the line using ImageJ software. Immunohistochemistry. Paraffin-embedded and frozen tissues were used for immunohistochemical analysis. For paraffin-embedded sections, samples were deparaffinized and rehydrated, treated with 3% H 2 O 2 in EtOH, treated with antigen retrieval solution (Vector Laboratories, Inc.), blocked with 10% donkey serum in phosphate-buffered saline (PBS), and then incubated with primary antibodies. For frozen sections, samples were fixed with acetone, treated with 0.3% H 2 O 2 in PBS, treated with 0.1 M ammonium chloride, blocked with 10% donkey serum in PBS, and then incubated with primary antibodies. Primary antibodies were detected with fluorescently labelled secondary antibodies. Primary antibodies used in this study were as follows: mouse anti-cTnT (Thermo Fisher Scientific), mouse anti-vinculin (Thermo Fisher), mouse anti-β -dystroglycan (Santa Cruz Biotechnology), mouse anti-Salv (Santa Cruz), rabbit anti-Yap1 (Novus Biologicals), rabbit anti-pYap (Cell Signaling Technology), rabbit anti-Aurkb (Abcam), rabbit anti-sarcomeric actinin (Abcam), rabbit anti-Ccne2 (Abcam), mouse anti-talin (Sigma-Aldrich), mouse anti-Cx43 (Santa Cruz), rabbit anti-active caspase-3 (Abcam) and rabbit anti-phospho-histone 3 (pH3) (Abcam). Secondary antibodies used in this study were as follows: Alexa-546-or Alexa-647-conjugated anti-rabbit (Thermo Fisher), biotin-conjugated anti-mouse (Vector) and Alexa-488-conjugated streptavidin (Thermo Fisher). Immunostained samples were analysed using a Leica TCS SP5 confocal microscope. Images were processed using Leica LAS AF software. Images from three different sections were documented for each sample.
For the quantification of cardiomyocytes positive for Aurkb, Yap, active caspase-3 and Ccne2, positively stained cardiomyocytes were quantified manually using ImageJ software. The observer was blinded to genotypes. The quantification of cardiomyocytes positive for Talin, Salv and pYap was performed by measuring pixel intensity in the cardiomyocyte cytoplasm. When images were captured, intensity was normalized to the level of staining in fibroblasts.
Deconvolution epifluorescence microscopy was performed in the Baylor College of Medicine Integrated Microscopy Core using an OMX-BLAZE 3D structured illumination microscope (GE Healthcare Life Systems). Images were acquired with an Olympus PlanApo 60× /1.42 objective, in z-stacks with 0.125 μ m spacing covering most of the tissue thickness. Images were deconvolved using a conservative algorithm. The maximum intensity projections and histograms were adjusted using SoftWorX 6.5.2. Three-dimensional volumes were also generated with the same software.
To quantify the number and size of cardiomyocytes, cells were delineated using wheat-germ agglutinin (WGA) conjugated to Alexa 647 (Thermo Fisher). Tissues were costained with anti-cTnT to label cardiomyocytes, and images were captured under a fluorescence microscope. The number and size of cardiomyocytes were quantified manually using ImageJ software. The observer was blinded to genotypes.
In cardiomyocytes stained for cTnT, sarcomere length was measured manually using ImageJ software. The observer was blinded to genotypes. Cardiomyocyte orientation angles were measured manually using ImageJ and were referenced to the plane of resection. EdU incorporation analysis. For EdU incorporation studies on P8 resection models, 0.25 mg of EdU (5-ethynly-2-deoxyurindine) was injected into apex-resected animals at 4 h before collection on four days after resection. EdU incorporation was analysed in paraffin-embedded tissues using a Click-it EdU Imaging kit (Thermo Fisher), followed by staining for cTnT and WGA. The number of EdU + nuclei was counted manually using ImageJ software. The observer was blinded to genotypes.
For EdU incorporation studies on adult TAC models, 100 μ g g −1 mouse of EdU was injected daily, starting at two days after surgery until one day before collection. Hearts were collected and nuclei were isolated for flow cytometry analysis according to previously described methods 20,21 . In brief, nuclei were stained with PCM1 antibody (Sigma-Aldrich) and for EdU using Click-it EdU Flow Cytometry Assay kit (Thermo Fisher). Analysis of nuclei was performed at Texas Heart Institute Flow Cytometry Core Facility using BD FACSAria (BD Biosciences). For EdU performed on sections, peri-fibrotic area was defined as within 350 μ m from the replacement fibrosis that was only observed in Mdx and Salv;Mdx dKO hearts. Collagen gel assay. We used the collagen gel assay to analyse P10 hearts, as previously described 6 . Gels were stained for cTnT and with DAPI to detect the migration of cardiomyocytes to the bottom gel. Quantitative PCR (qPCR). Total RNA was extracted from frozen heart tissue using the RNAeasy Micro kit (Qiagen). qPCR was performed as previously described 6 using the StepOnePlus Real-Time PCR System (LifeTechnologies). Immunoprecipitation and western blotting. Immunoprecipitation and western blotting were performed as previously described 5 , with the following minor modifications. Hearts were treated with modified radioimmunoprecipitation assay (RIPA) lysis buffer (50 mM Tris-HCl pH 7.4, 50 mM NaCl, 1 mM EDTA, 0.2% sodium deoxycholate, 0.05% sodium dodecyl sulphate (SDS), 0.2% Triton X-100, 0.5% NP-40) supplemented with complete protease and phosphatase inhibitors (Roche).
Protein concentration was determined using a Qubit Protein Assay kit on a Qubit 3.0 Fluorometer (Thermo Fisher). Primary antibodies used for immunoprecipitation were as follows: anti-Yap1 (5 μ g; Novus) and anti-Dag1 (3 μ g; Abcam). Anti-Flag M2 affinity gel (Sigma-Aldrich) was used for Flag pull-down assays. Primary antibodies used for immunoblotting were as follows: anti-Yap1 (1:1,000; Novus), letter reSeArCH anti-pYap (Ser127) (1:1,000; Cell Signaling), anti-Lats2 (1:500; Bethyl Laboratories), anti-Sgcδ (1:500; Santa Cruz), anti-Dag1 (1:500; Abcam), anti-αcatenin (1:50,000; Abcam), anti-HDAC2 (1:500; Thermo Fisher), anti-HSP90 (1:1,000; Thermo Fisher), anti-VEGFR2 (1:200; Thermo Fisher) and anti-Flag (1:1,000; Sigma-Aldrich).
For the Yap(5SA) experiments, expression of Yap(5SA) in cardiomyocytes was induced by tamoxifen injection starting five days before collection for four consecutive days. For experiments performed in C2C12 cells, subcellular protein lysate fractions were collected from differentiated C2C12 cells after short interfering (si)RNA-mediated knockdown of Salv and/or the gene encoding dystrophin (Dmd). Cell culture. C2C12 cells (ATCC CRL-1772) were cultured in Dulbecco's modified Eagle medium (DMEM; Thermo Fisher) supplemented with 20% fetal bovine serum (HyClone, GE Healthcare Life Systems) and 1× penicillin-streptomycin (Thermo Fisher). Cells were tested for mycoplasma using a Myco Probe mycoplasma detection kit (R&D Systems). To induce differentiation, confluent cells were treated with differentiation media containing DMEM supplemented with 2% horse serum (Thermo Fisher) and 1× penicillin-streptomycin.
For immunoprecipitation studies, cells were differentiated for seven days. For Dmd knockdown studies, Lipofectamine RNAiMax (Thermo Fisher) was used to transfect siRNA into differentiated cells two days before collection. Yap(5SA) (pCMV-Flag-Yap2) or GFP plasmid was transfected into C2C12 cells using Lipofectamine 3000 (Thermo Fisher) one day before the differentiation treatment was started. For subcellular fractionation, cells were differentiated for three days and treated with siRNA at day 1 of differentiation for 48 h before collection. Nuclear, cytoplasmic and plasma membrane fractions of cellular extracts were prepared using a subcellular protein fractionation kit for tissues (Thermo Fisher) according to the manufacturer's instructions. Recombinant GST-fusion proteins and binding assays. The GST-Yap1 plasmid was a gift from S. Piccolo. GST-Dag1 (β -dystroglycan domain, amino acids 652-893 of Dag1) and GST-Sgcδ (full-length, amino acids 1-289) were created by Gibson Assembly DNA cloning (NEB) using synthesized gBlocks gene fragments (IDT) for in-frame fusion with the GST moiety of pGEX-4T-2. For in vitro binding assays, purified GST proteins (500 mM) were treated with thrombin protease (GE Healthcare) to remove the GST tag. Cleaved proteins were then mixed with GST-Yap1 or GST-Dmd bound to glutathione beads and were rocked on ice for 3 h. Beads were washed three times by rocking in PBS containing 20 mM HEPES with 0.2% Triton X-100 at 4 °C for 5 min and were pelleted. Samples were separated using SDS-polyacrylamide gel electrophoresis, transferred to PVDF membranes, and analysed by western blotting. Estimation of cardiomyocyte numbers in sections. For each section, the total number of cardiomyocytes was estimated from the number of cardiomyocytes in a 0.1 mm 2 area multiplied by the total area. Statistical analysis. The n number for each experiments and analysis used in each panel are stated in the figure legends. All bar graphs except for Extended Data Fig. 1o represent mean ± s.e.m. Data availability. The data that support the findings of this study are available from the corresponding author upon reasonable request.
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Extended Data Figure 1 | Cardiomyocyte alignment after apical resection in P8 mouse hearts. a-o, Hearts were collected 21 days, after apical resection was performed in P8 mice. Hearts of control (a, e, i), Mdx (b, f, j), Salv cKO (c, g, k) and Salv;Mdx dKO (d, h, l) mice were stained for cTnT and wheat-germ agglutinin (WGA) for cardiomyocytes and cell membranes, respectively. For control and Mdx hearts, the apex regions above the scar are shown. For Salv cKO and Salv;Mdx dKO hearts, the apex regions that regenerated are shown. m, Sarcomere length in cardiomyocytes was measured. Groups were compared using a one-way ANOVA (n = 3 for each genotype). No statistically significant difference was observed between samples. Data are mean ± s.e.m. n, o, Cardiomyocyte orientation in either the border zone or repaired area. n, A representative image shows how the orientation angles of cardiomyocytes were measured. Angles referenced to the plane of resection were measured for each cardiomyocyte. A total of 50 cardiomyocytes were measured for each sample. o, Histograms showing the distribution of cardiomyocyte orientation angles for each genotype (n = 3 for each genotype; 150 cardiomyocytes total were analysed for each genotype). Variance between genotype groups was compared using an F-test. (p, s) , peri-fibrotic area of Mdx (q, t), Salv cKO (u, x), Salv;Mdx dKO (v, y) and peri-fibrotic area of dKO (w, z) mice after TAC surgery collected after two weeks. Cardiomyocytes were stained for actinin and cells were delineated by WGA. Arrowheads show EdU + cardiomyocytes. Quantification of EdU + cardiomyocytes is shown in Fig. 3n . Peri-fibrotic area is defined in Methods.
